ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
424K |
0 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
1.3K
|
424K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.3M |
3 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
12K
|
6.3M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
384
|
177K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Names Robin VanDenburgh as SVP of Sales
|
|
whytee
|
26 |
7.2K |
0 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
26
|
7.2K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
384
|
177K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
384
|
177K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
3 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
384
|
177K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
384
|
177K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
384
|
177K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
384
|
177K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
424K |
0 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
1.3K
|
424K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.3M |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
12K
|
6.3M
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Names Robin VanDenburgh as SVP of Sales
|
|
whytee
|
26 |
7.2K |
0 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
26
|
7.2K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
12K |
6.3M |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
12K
|
6.3M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
384
|
177K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
384
|
177K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
384
|
177K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
5 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
whytee
|
11K |
3.6M |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
11K
|
3.6M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
whytee
|
11K |
3.6M |
1 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
11K
|
3.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
1 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
384
|
177K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
11 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
11
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
298 |
74K |
1 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
298
|
74K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
384
|
177K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
298 |
74K |
4 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
298
|
74K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
298 |
74K |
6 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
298
|
74K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
298 |
74K |
2 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
298
|
74K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
384 |
177K |
2 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
384
|
177K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
298 |
74K |
3 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
298
|
74K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
298 |
74K |
4 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
298
|
74K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
whytee
|
18K |
7.0M |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
18K
|
7.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix
|
|
whytee
|
47 |
14K |
1 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
47
|
14K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
424K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.3K
|
424K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
6
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.7K |
9 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.7K
|
9
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.2K |
1.4M |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.7K |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.7K
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.7K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.7K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.9K |
2.9M |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
5.9K
|
2.9M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
5.9K |
2.9M |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
5.9K
|
2.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
9.8K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
9.8K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
9.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
42K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
42K
|
0
|
|